Clinical Trial Update: Cellular Reprogramming-Enhanced Skin Grafting for Diabetic Foot Ulcers [NA]

View source ↗

Summary

Clinical trial update indicating the completed status of a study on cellular reprogramming-enhanced skin grafting for diabetic foot ulcers (NCT02070835).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Snippet

Sponsor: Hu Zhicheng | Conditions: Diabetic Foot Ulcer | NA | Status: COMPLETED